(R)-4-Amino-3-(4-fluorophenyl)butanoic acid

95%

Reagent Code: #230084
fingerprint
CAS Number 741217-33-4

science Other reagents with same CAS 741217-33-4

blur_circular Chemical Specifications

scatter_plot Molecular Information
Weight 197.21 g/mol
Formula C₁₀H₁₂FNO₂
badge Registry Numbers
MDL Number MFCD11520152
thermostat Physical Properties
Boiling Point 329.1°C
inventory_2 Storage & Handling
Storage 2-8°C

description Product Description

Used as a chiral intermediate in the synthesis of central nervous system (CNS) pharmaceuticals, particularly GABA receptor modulators similar to baclofen analogs. These are employed in treating conditions such as epilepsy, spasticity, anxiety, and muscle relaxation. Its (R)-enantiomeric form enables the development of enantiomerically pure drugs with enhanced efficacy and reduced side effects. Additionally, derivatives are researched for potential as enzyme inhibitors in neurodegenerative diseases like Alzheimer's and Parkinson's due to structural resemblance to neurotransmitter analogs.

shopping_cart Available Sizes & Pricing

Size Availability Unit Price Quantity
inventory 250mg
10-20 days ฿1,890.00
inventory 1g
10-20 days ฿5,530.00
inventory 5g
10-20 days ฿19,410.00

Cart

No products

Subtotal: 0.00
Total 0.00 THB
(R)-4-Amino-3-(4-fluorophenyl)butanoic acid
No image available
Used as a chiral intermediate in the synthesis of central nervous system (CNS) pharmaceuticals, particularly GABA receptor modulators similar to baclofen analogs. These are employed in treating conditions such as epilepsy, spasticity, anxiety, and muscle relaxation. Its (R)-enantiomeric form enables the development of enantiomerically pure drugs with enhanced efficacy and reduced side effects. Additionally, derivatives are researched for potential as enzyme inhibitors in neurodegenerative diseases like Alzh
Used as a chiral intermediate in the synthesis of central nervous system (CNS) pharmaceuticals, particularly GABA receptor modulators similar to baclofen analogs. These are employed in treating conditions such as epilepsy, spasticity, anxiety, and muscle relaxation. Its (R)-enantiomeric form enables the development of enantiomerically pure drugs with enhanced efficacy and reduced side effects. Additionally, derivatives are researched for potential as enzyme inhibitors in neurodegenerative diseases like Alzheimer's and Parkinson's due to structural resemblance to neurotransmitter analogs.
Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Purchase History for

Loading purchase history...